TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer
Clinical trial NCT04471480 · UNKNOWN
Trial details
- NCT number
- NCT04471480
- Sponsor
- Dong Wang
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-08-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.